Примери за използване на Interferon alpha на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Interferon alpha.
The main method of treatment involves the use of interferon alpha.
Interferon alpha has demonstrated promising results in study.
The replacement acts in same way as naturally produced interferon alpha.
Safety study of pegylated interferon alpha 2b to treat polycythemia vera(PEGINVERA).
Interferon alpha(Intron A) is an injection usually given three times a week for 6 months to 1 year.
Children are particularly prone to develop depression when being treated with Rebetol and interferon alpha.
Preliminary data indicates that interferon alpha therapy may be associated with an increased rate of kidney.
The replacement interferon alfa-2b acts in same way as naturally produced interferon alpha.
Interferon Alpha(Intron A) is given by injection several times a week for six months to a year, or sometimes longer.
Children and adolescents are particularly prone to develop depression when being treated with ribavirin and interferon alpha.
Interferon Alpha(Intron A) is given by injection several times a week usually for 6 months to 1 year, but treatment can be longer.
To combat liver damage such as cirrhosis or liver cancer,doctors may prescribe Interferon Alpha, Lamivudine, or Baraclude.
Interferon alpha, interferon beta, and interferon gamma have overlapping yet distinct biologic activities.
Systemic immunotherapy treats the whole body by administering an agent such as the protein interferon alpha that can shrink tumors.
Preliminary data indicates that interferon alpha therapy may be associated with an increased rate of kidney graft rejection.
These included a study involving 1,106 adults that compared Glivec with the combination of interferon alpha plus cytarabine(other anticancer medicines).
Hepatitis C treated with interferon alpha, it has also been reported in patients with oncologic diseases treated with interferon alpha.
Pulmonary infiltrates, pneumonitis, and pneumonia, occasionally resulting in fatality, have been observed rarely in interferon alpha treated patients.
Some patients with hepatitis C benefit from treatment with interferon alpha or a combination of interferon alpha and ribavirin.
Prompt discontinuation of interferon alpha administration and treatment with corticosteroids appear to be associated with resolution of pulmonary adverse events.
If the chest X-ray shows pulmonary infiltrates or there is evidence of pulmonary function impairment,the patient is to be monitored closely, and, if appropriate, discontinue interferon alpha.
Approved Hepatitis B Drugs in the United States* Interferon Alpha(Intron A) is given by injection several times a week for six months to a year, or sometimes longer.
Note that interferon alpha does not guarantee the complete disposal of hepatitis C, however, it reduces the risk of developing cirrhosis and enhances the quality of life.
The combination can also be used to treat adults who have already failed treatment with an interferon alpha or peginterferon alpha in combination with ribavirin or interferon alpha alone.
Additional drugs including interferon alpha, rituximab, and anti-interleukin-5(IL-5) are being studied as potential treatment for individuals with Churg-Strauss syndrome.
The combination of Pegasys and ribavirin is indicated in naive patients andpatients who have failed previous treatment with interferon alpha(pegylated or non-pegylated) alone or in combination therapy with ribavirin.
Prompt discontinuation of interferon alpha administration and treatment with corticosteroids appear to be associated with resolution of pulmonary adverse events.
Gout medicines(allopurinol),- blood-thinning medicines(coumarin,warfarin),- medicines for seizures or tremors(phenytoin),- interferon alpha,- radiotherapy and certain medicines used to treat cancer folinic acid, oxaliplatin.
Imiquimod induces the release of interferon alpha(IFN-α) and other cytokines from a variety of human and animal cells(e.g. from human monocytes/macrophages and keratinocytes).